SCHEMBL798405

SCHEMBL798405

CCOC(=O)N(CC)c1ccc(Br)s1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.40
POLB P06746 2/20 0.39
ALDH1A1 P00352 6/20 0.36
GAA P10253 2/20 0.36
MAPK1 P28482 2/20 0.36
MAPT P10636 1/20 0.36
LMNA P02545 2/20 0.35
KMT2A Q03164 3/20 0.34
CES2 O00748 1/20 0.34
CES1 P23141 1/20 0.34
GSK3B P49841 1/20 0.34
RXFP1 Q9HBX9 2/20 0.34
HPGD P15428 2/20 0.34
PPARG P37231 2/20 0.34
NCOA2 Q15596 2/20 0.34
MEN1 O00255 1/20 0.34
ESR1 P03372 1/20 0.34
ALOX12 P18054 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5565183 0.72 NPSR1 (0.42) TSHRPOLBALDH1A1GAAMAPK1
SCHEMBL1400828 0.68 ALDH1A1 (0.63) TSHRPOLBALDH1A1MAPTLMNA
SCHEMBL64687 0.68 HDAC3 (0.58) TSHRPOLBALDH1A1GAAMAPT
SCHEMBL9139083 0.68 TSHR (0.58) TSHRPOLBALDH1A1GAALMNA
SCHEMBL3958438 0.67 HDAC3 (0.57) TSHRPOLBALDH1A1GAAMAPT
SCHEMBL9224528 0.67 TSHR (0.50) TSHRALDH1A1MAPTKMT2AHPGD
SCHEMBL10710710 0.67 TSHR (0.57) TSHRALDH1A1GAAMAPTLMNA
SCHEMBL24100191 0.67 GBA1 (0.53) TSHRALDH1A1GAAMAPK1MAPT
SCHEMBL12449209 0.67 CES2 (0.39) POLBALDH1A1GAAMAPTLMNA
SCHEMBL14375968 0.66 TSHR (0.56) TSHRALDH1A1MAPTLMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2627648-A1 17aHYDROXYLASE/C17,20-LYASE INHIBITORS Novartis AG (CH) 2013-08-21 EP disclosed
WO-2012035078-A1 17α-HYDROXYLASE/C17,20-LYASE INHIBITORS NOVARTIS AG (CH) 2012-03-22 WO disclosed